User menu

A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited

Bibliographic reference Laleman, Wim ; Vander Elst, Ingrid ; Zeegers, Marcel ; Servaes, Roger ; Libbrecht, Louis ; et. al. A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited. In: European Journal of Clinical Investigation, Vol. 36, no.4, p. 242-249 (2006)
Permanent URL http://hdl.handle.net/2078/187289
  1. Stewart Stephen F, Day Christopher P, The management of alcoholic liver disease, 10.1016/s0168-8278(02)00427-0
  2. Lee FY, Ascites Ren Dysfunct Liv Dis Pathog Diagn Treat, 1, 365 (1999)
  3. Dashti H, Eur Surg Res, 21, 83 (1989)
  4. Ariosto F, Eur Surg Res, 21, 280 (1989)
  5. Colombato LA, Portal Hypertension - Proceedings of the 79th Falk Symposium., 3 (1995)
  6. Kountouras J, Br J Exp Pathol, 65, 305 (1984)
  7. Franco Dominique, Portal Hypertension After Bile Duct Obstruction : Effect of Bile Diversion on Portal Pressure in the Rat, 10.1001/archsurg.1979.01370330086016
  8. Lebrec D., Blanchet L., Effect of Two Models of Portal Hypertension on Splanchnic Organ Blood Flow in the Rat, 10.1042/cs0680023
  9. Petermann Henning, Vogl Siegfried, Schulze Eberhardt, Dargel Rolf, Chronic liver injury alters basal and stimulated nitric oxide production and 3H-thymidine incorporation in cultured sinusoidal endothelial cells from rats, 10.1016/s0168-8278(99)80226-8
  10. Li Xiangnong, Benjamin Irving S, Alexander Barry, Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality, 10.1016/s0168-8278(02)00011-9
  11. Proctor E, Gastroenterology, 83, 1183 (1982)
  12. Van Roey G., Lijnen P., Verbesselt R., Verbruggen A., Fevery J., Effect of Narcotic Agents and of Bleeding on Systemic and Renal Haemodynamics in Healthy and CCl4-treated Cirrhotic Rats, 10.1042/cs0930549
  13. Laleman Wim, Omasta Anita, Van de Casteele Marc, Zeegers Marcel, Vander Elst Ingrid, Van Landeghem Lien, Severi Tamara, van Pelt Jos, Roskams Tania, Fevery Johan, Nevens Frederik, A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis, 10.1002/hep.20968
  14. Van de Casteele M, In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats, 10.1136/gut.51.3.440
  15. Geller SA, Pathology of the Liver, 943 (2002)
  16. Shah V, Am J Physiol Gastrointest Liver Physiol, 280, G1209 (2001)
  17. Calès Paul, Oberti Frédéric, Veal Nary, Fort Joël, Kaassis Mehdi, Moal Frédéric, Aubé Christophe, Vuillenin Eric, Pilette Christophe, Rifflet Hervé, Trouvé Renaud, Splenorenal shunt blood flow by transit-time ultrasound as an index of collateral circulation in portal hypertensive rats : Splenorenal Shunt Blood Flow by Transit-Time Ultrasound as an Index of Collateral Circulation in Portal Hypertensive Rats, 10.1002/hep.510280515
  18. Fernandez M, Garcia-Pagan JC, Casadevall M, Mourelle MI, Pique JM, Bosch J, Rodes J, Acute and chronic cyclooxygenase blockage in portal-hypertensive rats: Influence in nitric oxide biosynthesis, 10.1053/gast.1996.v110.pm8613060
  19. Graupera M, Cyclooxygenase-derived products modulate the increased intrahepatic resistance of cirrhotic rat livers, 10.1053/jhep.2003.50004
  20. Gupta Tarun K., Toruner Murat, Chung Moon K., Groszmann Roberto J., Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats, 10.1002/hep.510280405
  21. Wink DA, Meth Enz, 268, 120 (1996)
  22. Chieli Elisabetta, Malvaldi Gino, Role of the microsomal fad-containing monooxygenase in the liver toxicity of thioacetamide S-oxide, 10.1016/0300-483x(84)90154-9
  23. Brodehl Johannes, Thioacetamid in der experimentellen Leberforschung, 10.1007/bf01482654
  24. Porter WR, Drug Metab Dispos, 6, 379 (1978)
  25. Desmet Valeer J, Roskams Tania, Cirrhosis reversal: a duel between dogma and myth, 10.1016/j.jhep.2004.03.007
  26. Roskams T, Baptista A, Bianchi L, Burt A, Callea F, Denk H, De Groote J, Desmet V, Hubscher S, Ishak K, MacSween R, Portmann B, Poulson H, Scheuer P, Terracciano L, Thaler H, Histopathology of portal hypertension: a practical guideline, 10.1046/j.1365-2559.2003.01464.x
  27. Le Bail Brigitte, Bernard Pierre-Henri, Carles Jacques, Balabaud Charles, Bioulac-Sage Paulette, Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants, 10.1016/s0168-8278(97)80321-2
  28. Libbrecht Louis, Desmet Valeer, Roskams Tania, Preneoplastic lesions in human hepatocarcinogenesis : Preneoplastic lesions in human liver, 10.1111/j.1478-3231.2005.01016.x
  29. Kojiro Masamichi, Roskams Tania, Early Hepatocellular Carcinoma and Dysplastic Nodules, 10.1055/s-2005-871193
  30. Libbrecht Louis, Desmet Valeer, Damme Boudewijn Van, Roskams Tania, The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells, 10.1016/s0168-8278(00)80162-2
  31. Sherlock S, Diseases of the Liver and Biliary System, 365 (2002)
  32. Bosch Jaime, García-Pagán Juan Carlos, Complications of cirrhosis. I. Portal hypertension, 10.1016/s0168-8278(00)80422-5
  33. Arroyo V., Jiménez W., Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem, 10.1016/s0168-8278(00)80423-7
  34. Laleman Wim, Landeghem Lien, Wilmer Alexander, Fevery Johan, Nevens Frederik, Portal hypertension: from pathophysiology to clinical practice, 10.1111/j.1478-3231.2005.01163.x
  35. Bolognesi M., Merkel C., Sacerdoti D., Nava V., Gatta A., Role of spleen enlargement in cirrhosis with portal hypertension, 10.1016/s1590-8658(02)80246-8
  36. Navasa Miquel, Chesta Jaime, Bosch Jaume, Rodés Joan, Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis, 10.1016/0016-5085(89)91630-2
  37. Bhathal Prithi S., Grossman Howard J., Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators, 10.1016/s0168-8278(85)80770-4
  38. Graupera Mariona, Garcı́a-Pagán Joan-Carles, Parés Mireia, Abraldes Juan G, Roselló Joan, Bosch Jaume, Rodés Juan, Cyclooxygenase-1 inhibition corrects endothelial dysfunction in cirrhotic rat livers, 10.1016/s0168-8278(03)00347-7
  39. Pinzani M, Milani S, De Franco R, Grappone C, Caligiuri A, Gentilini A, Tosti- Guerra C, Maggi M, Failli P, Ruocco C, Gentilini P, Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells, 10.1053/gast.1996.v110.pm8566602
  40. Rockey Don C., Chung John J., Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: Endothelial dysfunction in portal hypertension, 10.1016/s0016-5085(98)70487-1
  41. Van de Casteele Marc, van Pelt Jos F, Nevens Frederik, Fevery Johan, Reichen Jürg, 10.1186/1476-5926-2-2
  42. Wiest R, The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough, 10.1053/jhep.2002.31432